Below are the financial statements of Neurocrine Biosciences, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 as of 2024-12-31 | 2023 as of 2023-12-31 |
|---|---|---|
| Assets | — | — |
| Current assets | — | — |
| Cash and cash equivalents | 233a | 251.1a |
| Available-for-sale debt securities | 843.1a | 780.5a |
| Accounts receivable | 479.1a | 439.3a |
| Inventory | 57.4a | 38.3a |
| Other current assets | 112.1a | 97.8a |
| Total current assets | 1,724.7a | 1,607a |
| Deferred tax assets | 485.7a | 362.6a |
| Available-for-sale debt securities | 739.5a | 687.5a |
| Right-of-use assets | 509.4a | 276.5a |
| Equity investments | 124.8a | 161.9a |
| Property and equipment, net | 82.6a | 70.8a |
| Intangible assets, net | 36.5a | 35.5a |
| Other noncurrent assets | 15.5a | 49.6a |
| Total assets | 3,718.7a | 3,251.4a |
| Liabilities and stockholders’ equity | — | — |
| Current liabilities | — | — |
| Accounts payable and accrued liabilities | 461.6a | 448.8a |
| Convertible senior notes | 0a | 170.1a |
| Other current liabilities | 46.1a | 35.9a |
| Total current liabilities | 507.7a | 654.8a |
| Noncurrent operating lease liabilities | 455.1a | 258.3a |
| Other noncurrent liabilities | 166.2a | 106.3a |
| Total liabilities | 1,129a | 1,019.4a |
| Stockholders’ equity | — | — |
| Preferred stock | 0a | 0a |
| Common stock | 0.1a | 0.1a |
| Additional paid-in capital | 2,554.6a | 2,382a |
| Accumulated other comprehensive income | 5.8a | 7a |
| Retained earnings (accumulated deficit) | 29.2a | -157.1a |
| Total stockholders’ equity | 2,589.7a | 2,232a |
| Total liabilities and stockholders’ equity | 3,718.7a | 3,251.4a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Neurocrine Biosciences’s data sources below and access millions more through our Disclosure Search.